Jeff Yass’s Pulse Biosciences PLSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $987K | Sell |
35,600
-18,400
| -34% | -$434K | ﹤0.01% | 8232 |
|
|
2026
Q1 | $1.17M | Buy |
54,000
+25,600
| +90% | +$473K | ﹤0.01% | 7483 |
|
|
2025
Q4 | $390K | Sell |
28,400
-1,000
| -3% | -$15.6K | ﹤0.01% | 9348 |
|
|
2025
Q3 | $520K | Sell |
29,400
-8,100
| -22% | -$128K | ﹤0.01% | 8844 |
|
|
2025
Q2 | $566K | Sell |
37,500
-22,100
| -37% | -$367K | ﹤0.01% | 8884 |
|
|
2025
Q1 | $959K | Sell |
59,600
-23,200
| -28% | -$432K | ﹤0.01% | 7359 |
|
|
2024
Q4 | $1.44M | Sell |
82,800
-30,000
| -27% | -$529K | ﹤0.01% | 6045 |
|
|
2024
Q3 | $1.98M | Sell |
112,800
-15,700
| -12% | -$268K | ﹤0.01% | 5286 |
|
|
2024
Q2 | $1.44M | Sell |
128,500
-90,100
| -41% | -$849K | ﹤0.01% | 5760 |
|
|
2024
Q1 | $1.9M | Buy |
218,600
+900
| +0.4% | +$8.27K | ﹤0.01% | 5459 |
|
|
2023
Q4 | $2.66M | Buy |
217,700
+53,600
| +33% | +$371K | ﹤0.01% | 4785 |
|
|
2023
Q3 | $661K | Buy |
164,100
+143,700
| +704% | +$893K | ﹤0.01% | 7586 |
|
|
2023
Q2 | $147K | Sell |
20,400
-164,300
| -89% | -$1.05M | ﹤0.01% | 10601 |
|
|
2023
Q1 | $621K | Sell |
184,700
-131,900
| -42% | -$398K | ﹤0.01% | 8040 |
|
|
2022
Q4 | $877K | Sell |
316,600
-99,700
| -24% | -$224K | ﹤0.01% | 6473 |
|
|
2022
Q3 | $957K | Buy |
+416,300
| New | +$676K | ﹤0.01% | 6739 |
|
|
2021
Q4 | – | Sell |
-96,800
| Closed | -$2.09M | – | 13724 |
|
|
2021
Q3 | $2.09M | Buy |
+96,800
| New | +$2.08M | ﹤0.01% | 5734 |
|
|
2021
Q1 | – | Sell |
-25,300
| Closed | -$604K | – | 12702 |
|
|
2020
Q4 | $604K | Buy |
+25,300
| New | +$402K | ﹤0.01% | 7870 |
|
|
2020
Q3 | – | Sell |
-36,900
| Closed | -$386K | – | 11005 |
|
|
2020
Q2 | $386K | Buy |
36,900
+6,200
| +20% | +$55.8K | ﹤0.01% | 7886 |
|
|
2020
Q1 | $220K | Buy |
30,700
+10,700
| +54% | +$111K | ﹤0.01% | 8520 |
|
|
2019
Q4 | $268K | Sell |
20,000
-500
| -2% | -$7.12K | ﹤0.01% | 8231 |
|
|
2019
Q3 | $317K | Sell |
20,500
-82,700
| -80% | -$1.07M | ﹤0.01% | 8181 |
|
|
2019
Q2 | $1.36M | Buy |
103,200
+10,500
| +11% | +$143K | ﹤0.01% | 4990 |
|
|
2019
Q1 | $1.63M | Buy |
+92,700
| New | +$1.45M | ﹤0.01% | 4085 |
|
|
2018
Q3 | – | Sell |
-22,500
| Closed | -$341K | – | 10000 |
|
|
2018
Q2 | $341K | Sell |
22,500
-5,300
| -19% | -$89.7K | ﹤0.01% | 7584 |
|
|
2018
Q1 | $376K | Buy |
27,800
+800
| +3% | +$15.2K | ﹤0.01% | 7214 |
|
|
2017
Q4 | $637K | Sell |
27,000
-17,900
| -40% | -$422K | ﹤0.01% | 6153 |
|
|
2017
Q3 | $836K | Buy |
+44,900
| New | +$1.02M | ﹤0.01% | 5593 |
|
Other funds holding PLSE
PCM
Jeff Yass's PLSE Position: Q2 2026 in Review
Jeff Yass sold out of Pulse Biosciences (PLSE) in Q2 2026, closing a stake of 13,411 shares — an estimated $316K sold.
Jeff Yass first reported a position in PLSE in Q1 2018 and held it in 13 quarters. The position peaked at $696K in Q1 2021. 105 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.
- Jeff Yass reported no remaining Pulse Biosciences position as of Q2 2026 after selling out during the quarter.
- Jeff Yass sold 13,411 Pulse Biosciences shares in Q2 2026, an estimated $316K.
- Jeff Yass first reported a position in Pulse Biosciences in Q1 2018 and held it in 13 quarters.
- Jeff Yass's Pulse Biosciences position peaked at $696K in Q1 2021.
- 105 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.